TY - JOUR AU - Giuliani, Meredith Elana AU - Liu, Geoffrey AU - Xu, Wei AU - Dirlea, Mihaela AU - Selby, Peter AU - Papadakos, Janet AU - Abdelmutti, Nazek AU - Yang, Dongyang AU - Eng, Lawson AU - Goldstein, David Paul AU - Jones, Jennifer Michelle PY - 2019 DA - 2019/04/09 TI -为癌症患者实现一种新型的电子患者导向戒烟平台:间断时间序列分析JO - J Med Internet Res SP - e11735 VL - 21 IS - 4kw -肿瘤KW -戒烟KW -实施科学KW -质量改善AB -背景:接受治疗的癌症患者持续吸烟会导致治疗毒副作用和持续效应的发生率显著升高，复发和第二恶性肿瘤的风险增加，全因死亡率增加。尽管如此，常规的烟草使用筛查和提供戒烟治疗尚未在癌症环境中广泛实施。目的:本研究的目的是实施和评估一种创新的戒烟电子转诊系统(CEASE)的采用和影响，以促进癌症患者转诊到戒烟计划。方法:开发了一个以患者为导向的电子戒烟平台(CEASE)，以促进吸烟筛查和转诊，并在加拿大最大的癌症中心之一实施。实施和评价以渥太华研究使用模式为指导。采用间断时间序列设计来检验与之前基于论文的筛选方案相比，halt对筛查率、提供的转诊和接受的转诊的影响。对吸烟者或近期戒烟者的亚样本也进行了评估，并比较了实施前和实施后，以检验halt对后续接触戒烟计划和戒烟尝试的影响。结果:在20个月的研究期间，共有17,842名新患者就诊。该平台已在所有疾病地点成功实施。 Screening rates increased from 44.28% (2366/5343) using the paper-based approach to 65.72% (3538/5383) using CEASE (P<.01), and referrals offered to smokers who indicated interest in quitting increased from 18.6% (58/311) to 98.8% (421/426; P<.01). Accepted referrals decreased from 41% (24/58) to 20.4% (86/421), though the overall proportion of referrals generated from total current/recent tobacco users willing to quit increased from 5.8% (24/414) to 20.2% (86/426) due to the increase in referrals offered. At 1-month postscreening, there was no significant difference in the proportion that was currently using tobacco and had not changed use in the past 4 weeks (pre: 28.9% [24/83] and post: 28.8% [83/288]). However, contact with the referral program increased from 0% to 78% in the postCEASE cohort (P<.001). Conclusions: CEASE is an innovative tool to improve smoking screening and can be implemented in both a time- and cost-effective manner which promotes sustainability. CEASE was successfully implemented across all clinics and resulted in improvements in overall screening and referral rates and engagement with referral services. SN - 1438-8871 UR - //www.mybigtv.com/2019/4/e11735/ UR - https://doi.org/10.2196/11735 UR - http://www.ncbi.nlm.nih.gov/pubmed/30964445 DO - 10.2196/11735 ID - info:doi/10.2196/11735 ER -